Spot Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Spot Trading’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,100	Closed	-$99.7K	–	3520
2016 Q3	$95K	Buy	5,100 +2,023	+66%	+$38.2K	﹤0.01%	2426
2016 Q2	$50K	Buy	+3,077	New	+$45.3K	﹤0.01%	2766

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's BEAT Position: Q4 2016 in Review

Spot Trading sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 5,100 shares — an estimated $99.7K sold.

Spot Trading first reported a position in BEAT in Q2 2016 and held it in 2 quarters. The position peaked at $95K in Q3 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

Spot Trading reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
Spot Trading sold 5,100 BioTelemetry, Inc. shares in Q4 2016, an estimated $99.7K.
Spot Trading first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 2 quarters.
Spot Trading's BioTelemetry, Inc. position peaked at $95K in Q3 2016.
160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.